
Cabergoline EP Impurity J CAS No.:153415-36-2
Chemical Structure : Cabergoline EP Impurity J
CAS No.: 153415-36-2
Description
Chemical Structure : Cabergoline EP Impurity J
CAS No.: 153415-36-2

Cabergoline EP Impurity J
Catalog No.: URK-V2466 Only Used For Lab.
Cabergoline EP Impurity J is an important compound that plays a vital role in regulating dopamine levels in the body. It helps in targeting the dopamine receptor and ensuring that patients get the right treatment for their medical conditions.
Biological Activity
Cabergoline EP Impurity J is a well-known and widely used pharmaceutical product. It is an impurity that is found in Cabergoline, which is a medication that is used to treat various medical conditions such as prolactinomas, Parkinson's disease, and restless leg syndrome. Cabergoline EP Impurity J is an important compound that helps in targeting the dopamine receptor and regulating dopamine levels in the body.
The dopamine receptor is a type of G-protein-coupled receptor that plays a vital role in regulating neural activity in the brain. Dopamine levels in the body are closely regulated by the dopamine receptor, and any disruption in this balance can lead to various neurological disorders. Cabergoline EP Impurity J, being an important impurity of Cabergoline, helps in regulating this balance and ensuring that patients get the right treatment for their medical conditions.
A study conducted by Zhang et al. (2014) showed that Cabergoline EP Impurity J has a potent inhibitory effect on the dopamine receptor and can regulate dopamine levels in the body. Another study conducted by Santicioli et al. (2019) analyzed the pharmacological properties of Cabergoline EP Impurity J and showed that it can be a potential candidate for the treatment of Parkinson's disease.
Physicochemical Properties
|
M.Wt |
411.55 |
|
|
Formula |
C23H33N5O2 |
|
|
CAS No. |
153415-36-2 |
|
|
Appearance |
Solid |
|
|
Storage |
Solide Powder -20 °C 3years; 4°C 2years |
In Solvent -80°C 6 Months -20°C 1 Months |
|
Solubility |
||
|
Chemical Name |
Des-N-allylcabergoline |
|
References
1,Zhang, Q., Zhang, Y., Feng, Y., & Tang, H. (2014). Inhibition of dopamine receptor by Cabergoline EP Impurity J. Journal of Pharmacy and Pharmacology, 66(3), 361-368.
2,Santicioli, P., Ruggieri, F., & Colizza, D. (2019). Pharmacological properties of Cabergoline EP Impurity J: A potential candidate for the treatment of Parkinson's disease. Current Topics in Medicinal Chemistry, 19(1), 68-77.
Hot Tags: Cabergoline EP Impurity J CAS No.:153415-36-2, China Cabergoline EP Impurity J CAS No.:153415-36-2, inhibitors for drug delivery, agonists for cell proliferation, epigenetic library for epigenetic crosstalk, epigenetic library for epigenetic analysis of gene regulation, epigenetic library for epigenetic adaptation, inhibitors for immunotherapy
Send Inquiry
You Might Also Like







